Xylyx Bio, a leader in predictive disease models, today announced the release of its IN SITE™ Metastasis Kit, a highly physiologic system that contains complex site-specific microenvironments to provide scientists with much-needed insight into cancer disease biology and the efficacy of drug candidates. Read more >>
President and CEO of Boston Harbor Angels, Ziad Moukheiber, to speak at expert panel at Founders Live Boston on Thursday, May 28. Read more >>
Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced the publication of two abstracts at the European League Against Rheumatism (EULAR) 2020 E-Congress that will be taking place June 3-6, 2020.Read more >>
Three early-stage investors spoke with the Greentown Labs community this month about different types of investors, how to build investor relationships, and advice for approaching fundraising in an uncertain economy. The panel, which was part of Greentown’s Investor Speaker Series, featured Deb Kemper, managing partner of Golden Seeds Ventures, Christopher Mirabile, chair emeritus and public policy chair emeritus of the Angel Capital Association, and Ziad H. Moukheiber, president and CEO of Boston Harbor Angels. Read more >>
Canned wine isn’t just found on grocery store shelves and at outdoor festivals these days…An increasing awareness of sustainability and wellness among consumers may bolster the positioning of premium canned wine in the marketplace. Organic farming and energy conservation are integral to the philosophy behind canned wine brand Archer Roose, founded in 2015, as does the aluminum package. Read more >>
Aircuity in Newton announced that Tom Nasti joined the company as the vice president of operations. Read more >>
Wasabi on list. Read more >>
CytoAgents awarded $1.6 million National Institutes of Health (NIH) grant to accelerate treatment for cytokine storm. Read more >>
Premama Wellness, a Providence-based startup that sells supplements for maternity wellness, has attracted its first institutional investor since launching in 2011: District Ventures Capital, a Canadian venture capital fund hyper-focused on the food, beverage and health and wellness sectors. Read more >>
Emovi, Inc., a Canadian medical device company, announced today that they were selected to join the Canadian Technology Accelerator (CTA) in Boston, MA. Emovi was selected with 10 other companies to participate in the 2020 cohort. Read more >>
